trending Market Intelligence /marketintelligence/en/news-insights/trending/lbvbobkbnlpqsd_i1dvgvw2 content esgSubNav
In This List

UroGen Pharma appoints COO

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


UroGen Pharma appoints COO

UroGen Pharma Ltd. appointed Stephen Mullennix as COO.

Mullennix previously served as the CFO and senior vice president of operations for SolarReserve LLC, a power company.